426. Gene Therapy-Mediated Reversal of Congenital Blindness: Demonstration of Efficacy in a Phase 1 Safety Trial

. (2009). 426. Gene Therapy-Mediated Reversal of Congenital Blindness: Demonstration of Efficacy in a Phase 1 Safety Trial. Molecular Therapy, 17(), S167–. doi:10.1016/s1525-0016(16)38784-6

An interview with Sci-Hub Founder Alexandra Elbakyan,Who exactly should pay for academic research